209 370

Cited 7 times in

Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis

DC Field Value Language
dc.contributor.author이승현-
dc.contributor.author전새봄-
dc.date.accessioned2023-03-27T02:42:39Z-
dc.date.available2023-03-27T02:42:39Z-
dc.date.issued2023-01-
dc.identifier.issn1226-3613-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/193673-
dc.description.abstractDynamic alteration of DNA methylation leads to various human diseases, including nonalcoholic fatty liver disease (NAFLD). Although C-Maf-inducing protein (Cmip) has been reported to be associated with NAFLD, its exact underlying mechanism remains unclear. Here, we aimed to elucidate this mechanism in NAFLD in vitro and in vivo. We first identified alterations in the methylation status of the Cmip intron 1 region in mouse liver tissues with high-fat high-sucrose diet-induced NAFLD. Knockdown of DNA methyltransferase (Dnmt) 1 significantly increased Cmip expression. Chromatin immunoprecipitation assays of AML12 cells treated with oleic and palmitic acid (OPA) revealed that Dnmt1 was dissociated and that methylation of H3K27me3 was significantly decreased in the Cmip intron 1 region. Conversely, the knockdown of Tet methylcytosine dioxygenase 2 (Tet2) decreased Cmip expression. Following OPA treatment, the CCCTC-binding factor (Ctcf) was recruited, and H3K4me3 was significantly hypermethylated. Intravenous Cmip siRNA injection ameliorated NAFLD pathogenic features in ob/ob mice. Additionally, Pparγ and Cd36 expression levels were dramatically decreased in the livers of ob/ob mice administered siCmip, and RNA sequencing revealed that Gbp2 was involved. Gbp2 knockdown also induced a decrease in Pparγ and Cd36 expression, resulting in the abrogation of fatty acid uptake into cells. Our data demonstrate that Cmip and Gbp2 expression levels are enhanced in human liver tissues bearing NAFLD features. We also show that Dnmt1-Trt2/Ctcf-mediated reversible modulation of Cmip methylation regulates the Gbp2-Pparγ-Cd36 signaling pathway, indicating the potential of Cmip as a novel therapeutic target for NAFLD.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherNature Publishing Group-
dc.relation.isPartOfEXPERIMENTAL AND MOLECULAR MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAdaptor Proteins, Signal Transducing / metabolism-
dc.subject.MESHAnimals-
dc.subject.MESHCD36 Antigens / genetics-
dc.subject.MESHCD36 Antigens / metabolism-
dc.subject.MESHDNA Methylation-
dc.subject.MESHDNA-Binding Proteins / metabolism-
dc.subject.MESHDioxygenases* / genetics-
dc.subject.MESHDioxygenases* / metabolism-
dc.subject.MESHGTP-Binding Proteins / metabolism-
dc.subject.MESHHumans-
dc.subject.MESHLiver / metabolism-
dc.subject.MESHMice-
dc.subject.MESHMice, Inbred C57BL-
dc.subject.MESHNon-alcoholic Fatty Liver Disease* / genetics-
dc.subject.MESHNon-alcoholic Fatty Liver Disease* / metabolism-
dc.subject.MESHPPAR gamma / genetics-
dc.subject.MESHPPAR gamma / metabolism-
dc.titleDnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Biochemistry and Molecular Biology (생화학-분자생물학교실)-
dc.contributor.googleauthorJangho Lee-
dc.contributor.googleauthorJi-Hye Song-
dc.contributor.googleauthorJae-Ho Park-
dc.contributor.googleauthorMin-Yu Chung-
dc.contributor.googleauthorSeung-Hyun Lee-
dc.contributor.googleauthorSae-Bom Jeon-
dc.contributor.googleauthorSo Hee Park-
dc.contributor.googleauthorJin-Taek Hwang-
dc.contributor.googleauthorHyo-Kyoung Choi -
dc.identifier.doi10.1038/s12276-022-00919-5-
dc.contributor.localIdA02932-
dc.contributor.localIdA06268-
dc.relation.journalcodeJ00860-
dc.identifier.eissn2092-6413-
dc.identifier.pmid36609599-
dc.contributor.alternativeNameLee, Seung Hyun-
dc.contributor.affiliatedAuthor이승현-
dc.contributor.affiliatedAuthor전새봄-
dc.citation.volume55-
dc.citation.number1-
dc.citation.startPage143-
dc.citation.endPage157-
dc.identifier.bibliographicCitationEXPERIMENTAL AND MOLECULAR MEDICINE, Vol.55(1) : 143-157, 2023-01-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Biochemistry and Molecular Biology (생화학-분자생물학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.